|
Under s196E of the Veteransí Entitlements Act 1986 the Repatriation Commission, an ex-service
person or eligible dependant, or an ESO representing veterans or their dependants, may ask the Repatriation Medical
Authority to carry out an investigation in respect of a particular kind of injury, disease or death, or to review
the contents of a Statement of Principles.
The following investigations have been concluded in 2001-2002:
1. osteoarthrosis;
2. motor neurone disease;
3. asthma;
4. carpal tunnel syndrome;
5. bronchiectasis;
6. chronic pancreatitis;
7. giant cell arteritis;
8. Meniereís disease; and
9. chronic lymphoid leukaemia;
10. acute lymphoid leukaemia;
11. congenital pes planus;
12. acquired pes planus;
13. chronic gastritis;
14. lumbar spondylosis;
15. otitis externa;
16. inflammatory periodontal disease;
17. multiple sclerosis;
18. adenocarcinoma of the kidney;
19. open-angle glaucoma;
20. Parkinsonís disease;
21. secondary parkinsonism;
22. malignant neoplasm of the bone or articular cartilage;
23. cervical spondylosis; and
24. thoracic spondylosis.
These investigations resulted in the revocation of existing Statements of Principles and the determination of
new Statements of Principles.
The investigation related to neuropathy [25] resulted in the determination of new Statements of Principles concerning
peripheral neuropathy. The investigation related to mesangial IGA glomerulonephritis [26] resulted in the determination
of new Statements of Principles concerning mesangial IGA glomerulonephritis. The investigation related to malignant
neoplasm of the anus [27] resulted in the determination of new Statements of Principles concerning malignant neoplasm
of the anal canal.
The investigation relating to multiple chemical sensitivity [28] resulted in the RMA issuing a statement that
it did not propose to make a Statement of Principles concerning multiple chemical sensitivity for the purposes
of subsection 196B(2) or (3) of the Veteransí Entitlements Act 1986 (the Act), for the reason that the RMA
formed the view that multiple chemical sensitivity is not a ìdiseaseî as defined in section 5D of
the Act.
The following investigations previously notified have not been concluded as at 30 June 2002:
1. Gulf War syndrome [the RMA is awaiting the outcome of the departmental Health Study before
concluding this investigation];
2. psoriasis;
3. atherosclerotic peripheral vascular disease;
4. osteoporosis;
5. malignant neoplasm of the brain;
6. malignant neoplasm of the colon;
7. carotid artery disease;
8. obesity;
9. macular degeneration.
The following investigations notified in the gazette during 2001/2002 have not been concluded as at 30 June
2001:
10. chronic sinusitis;
11. allergic rhinitis;
12. myeloma;
13. chronic fatigue syndrome;
14. atrial fibrillation;
15. gastro-oesophageal reflux disease;
16. diabetes mellitus;
17. ischaemic heart disease;
18. chronic myeloid leukaemia;
19. mitral valve prolapse;
20. malignant neoplasm of the oral cavity or hypopharynx;
21. malignant neoplasm of the salivary gland;
22. malignant neoplasm of the rectum;
23. aortic stenosis;
24. dental pulp disease(including pulpal abscess);
25. loss of teeth;
26. colorectal adenomatous polyp or familial adenomatous polyposis;
27. malignant neoplasm of the stomach;
28. hypertension;
29. non melanotic malignant neoplasm of the skin;
30. tinea;
31. melioidosis; and
32. subarachnoid haemorrhage. -
In summary, as at 30 June 2002, the RMA has completed 28 investigations for the 12 month period and has 32
ongoing investigations.
This page last updated 16 October 2002.
|
